Yung Zip Chemical Ind Co Ltd (4102) - Total Assets
Based on the latest financial reports, Yung Zip Chemical Ind Co Ltd (4102) holds total assets worth NT$927.10 Million TWD (≈ $29.21 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 4102 net asset value for net asset value and shareholders' equity analysis.
Yung Zip Chemical Ind Co Ltd - Total Assets Trend (2002–2024)
This chart illustrates how Yung Zip Chemical Ind Co Ltd's total assets have evolved over time, based on quarterly financial data.
Yung Zip Chemical Ind Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Yung Zip Chemical Ind Co Ltd's total assets of NT$927.10 Million consist of 41.2% current assets and 58.8% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 13.8% |
| Accounts Receivable | NT$67.81 Million | 7.0% |
| Inventory | NT$175.13 Million | 18.2% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2002–2024)
This chart illustrates how Yung Zip Chemical Ind Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Yung Zip Chemical Ind Co Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Yung Zip Chemical Ind Co Ltd's current assets represent 41.2% of total assets in 2024, an increase from 0.0% in 2002.
- Cash Position: Cash and equivalents constituted 13.8% of total assets in 2024, up from 7.9% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
- Asset Diversification: The largest asset category is inventory at 18.2% of total assets.
Yung Zip Chemical Ind Co Ltd Competitors by Total Assets
Key competitors of Yung Zip Chemical Ind Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Pfizer Inc
SA:PFIZ34
|
Brazil | R$208.73 Billion |
|
CSPC Pharmaceutical Group Limited
F:CVG
|
Germany | €46.00 Billion |
|
Aurora Optoelectronics Co Ltd
SHG:600666
|
China | CN¥1.60 Billion |
|
Shandong Keyuan Pharmaceutical Co. Ltd. A
SHE:301281
|
China | CN¥1.60 Billion |
|
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3
|
Brazil | R$3.83 Billion |
|
Pfizer Inc
NYSE:PFE
|
USA | $208.73 Billion |
|
Merck & Company Inc
NYSE:MRK
|
USA | $129.55 Billion |
|
Firebrick Pharma Ltd
AU:FRE
|
Australia | AU$1.83 Million |
Yung Zip Chemical Ind Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.96 | 3.49 | 2.19 |
| Quick Ratio | 1.03 | 2.12 | 1.07 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$180.84 Million | NT$294.05 Million | NT$197.23 Million |
Yung Zip Chemical Ind Co Ltd - Advanced Valuation Insights
This section examines the relationship between Yung Zip Chemical Ind Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.49 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -2.6% |
| Total Assets | NT$964.63 Million |
| Market Capitalization | $24.36 Million USD |
Valuation Analysis
Below Book Valuation: The market values Yung Zip Chemical Ind Co Ltd's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Yung Zip Chemical Ind Co Ltd's assets decreased by 2.6% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Yung Zip Chemical Ind Co Ltd (2002–2024)
The table below shows the annual total assets of Yung Zip Chemical Ind Co Ltd from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$964.63 Million ≈ $30.39 Million |
-2.59% |
| 2023-12-31 | NT$990.27 Million ≈ $31.20 Million |
-3.64% |
| 2022-12-31 | NT$1.03 Billion ≈ $32.38 Million |
+10.47% |
| 2021-12-31 | NT$930.25 Million ≈ $29.31 Million |
-2.45% |
| 2020-12-31 | NT$953.56 Million ≈ $30.04 Million |
+39.16% |
| 2019-12-31 | NT$685.20 Million ≈ $21.59 Million |
+11.71% |
| 2018-12-31 | NT$613.39 Million ≈ $19.33 Million |
+11.30% |
| 2017-12-31 | NT$551.14 Million ≈ $17.36 Million |
-0.44% |
| 2016-12-31 | NT$553.57 Million ≈ $17.44 Million |
-14.38% |
| 2015-12-31 | NT$646.53 Million ≈ $20.37 Million |
-2.62% |
| 2014-12-31 | NT$663.92 Million ≈ $20.92 Million |
-7.09% |
| 2013-12-31 | NT$714.59 Million ≈ $22.51 Million |
-11.43% |
| 2012-12-31 | NT$806.84 Million ≈ $25.42 Million |
-14.55% |
| 2011-12-31 | NT$944.18 Million ≈ $29.75 Million |
+28.98% |
| 2010-12-31 | NT$732.05 Million ≈ $23.06 Million |
+23.35% |
| 2009-12-31 | NT$593.47 Million ≈ $18.70 Million |
+14.54% |
| 2008-12-31 | NT$518.12 Million ≈ $16.32 Million |
-2.76% |
| 2007-12-31 | NT$532.84 Million ≈ $16.79 Million |
+2.11% |
| 2006-12-31 | NT$521.84 Million ≈ $16.44 Million |
+2.78% |
| 2005-12-31 | NT$507.71 Million ≈ $16.00 Million |
-7.07% |
| 2004-12-31 | NT$546.34 Million ≈ $17.21 Million |
-6.13% |
| 2003-12-31 | NT$581.99 Million ≈ $18.34 Million |
+5.71% |
| 2002-12-31 | NT$550.57 Million ≈ $17.35 Million |
-- |
About Yung Zip Chemical Ind Co Ltd
Yung Zip Chemical Ind. Co., Ltd. operates as a bulk drug manufacturing company worldwide. It offers active pharmaceutical ingredients (APIs) and excipients, API intermediates, and specialty chemicals, as well as custom research and manufacturing services. The company was founded in 1978 and is based in Taichung, Taiwan.